6EQI
Structure of PINK1 bound to ubiquitin
Summary for 6EQI
Entry DOI | 10.2210/pdb6eqi/pdb |
Descriptor | Ubiquitin, Nb696, Serine/threonine-protein kinase PINK1, putative, ... (5 entities in total) |
Functional Keywords | pink1 ubiquitin mitophagy nanobody substrate recognition complex parkinson's disease, transferase |
Biological source | Homo sapiens (Human) More |
Cellular location | Ubiquitin: Cytoplasm : P0CG48 |
Total number of polymer chains | 3 |
Total formula weight | 73264.99 |
Authors | Schubert, A.F.,Gladkova, C.,Pardon, E.,Wagstaff, J.L.,Freund, S.M.V.,Steyaert, J.,Maslen, S.,Komander, D. (deposition date: 2017-10-13, release date: 2017-11-08, Last modification date: 2024-10-23) |
Primary citation | Schubert, A.F.,Gladkova, C.,Pardon, E.,Wagstaff, J.L.,Freund, S.M.V.,Steyaert, J.,Maslen, S.L.,Komander, D. Structure of PINK1 in complex with its substrate ubiquitin. Nature, 552:51-56, 2017 Cited by PubMed Abstract: Autosomal-recessive juvenile Parkinsonism (AR-JP) is caused by mutations in a number of PARK genes, in particular the genes encoding the E3 ubiquitin ligase Parkin (PARK2, also known as PRKN) and its upstream protein kinase PINK1 (also known as PARK6). PINK1 phosphorylates both ubiquitin and the ubiquitin-like domain of Parkin on structurally protected Ser65 residues, triggering mitophagy. Here we report a crystal structure of a nanobody-stabilized complex containing Pediculus humanus corporis (Ph)PINK1 bound to ubiquitin in the 'C-terminally retracted' (Ub-CR) conformation. The structure reveals many peculiarities of PINK1, including the architecture of the C-terminal region, and reveals how the N lobe of PINK1 binds ubiquitin via a unique insertion. The flexible Ser65 loop in the Ub-CR conformation contacts the activation segment, facilitating placement of Ser65 in a phosphate-accepting position. The structure also explains how autophosphorylation in the N lobe stabilizes structurally and functionally important insertions, and reveals the molecular basis of AR-JP-causing mutations, some of which disrupt ubiquitin binding. PubMed: 29160309DOI: 10.1038/nature24645 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (3.1 Å) |
Structure validation
Download full validation report